from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0846c/-

LFCtreatmentdescriptionclass of inhibitor

-0.189

Amikacinug/mL Amikacintranslation

-0.447

Cap5-10ug/mL Capreomycintranslation

-0.397

Rox10-50 ug/mL Roxithromycintranslation

0.137

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.155

Rif0.2-5ug/mL Rifampicintranscription

-0.494

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.929

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.496

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.024

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.487

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.072

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.003

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.547

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.951

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.149

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.764

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.728

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.682

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.010

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.126

Nigericin50 uM Nigericinrespiration

-0.429

TRC10-150 ug/mL Triclosanrespiration

0.013

TRZ10-25 ug/mL Thioridazinerespiration

2.133

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.245

menadione6-10 ug/mL Menadionerespiration

-0.116

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.812

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.255

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.265

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.490

NRP_1Non-replicating persistence stage 1dosRassociated

-0.271

Amp0.2mg/mL AmpicillincellWall

-0.466

Cephalexin20-100 ug/mL CephalexincellWall

-0.515

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.216

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.175

EMB10-20 ug/mL EthambutolcellWall

-0.460

Eta12-40 ug/mL EthionamidecellWall

-0.616

INH0.2-0.4 ug/mL IsoniazidcellWall

0.356

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.157

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.216

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.059

BZA0.12 mg/mL BenzamidearomaticAmides

0.252

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.629

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.247

H2O24 mM hydrogen peroxideDNAdamaging

-0.282

Levo10 ug/mL LevofloxacinDNAdamaging

-0.016

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.382

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.618

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.354

UVUV-irradiationDNAdamaging

4.468

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.838

Antimycin12.5-50 ug/mL Antimycin A?

0.010

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.528

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.277

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.701

PA8240.2-2 ug/mL PA-824?

-0.773

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.907

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.645

Verapamil50 uM Verapamil?

-0.316

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.527

methoxatin10-20 ug/mL Methoxatin?